Press release
Neuropathic Pain Market to Reach USD 13.28 Billion by 2032
Neuropathic Pain Market
The global neuropathic pain market is experiencing robust growth, projected to expand from USD 8.58 billion in 2024 to USD 13.28 billion by 2032, at a CAGR of 5.6% during the forecast period. This surge is fueled by the increasing prevalence of chronic diseases such as diabetes and cancer, advancements in treatment options, and heightened awareness among healthcare professionals and patients.
Download your sample copy of this report today!https://www.maximizemarketresearch.com/request-sample/34992/
✿ Neuropathic Pain MarketCompetitive Landscape
The neuropathic pain market is characterized by the presence of several key players who are actively engaged in research and development, strategic partnerships, and product launches to enhance their market position. Notable companies include Pfizer Inc., Johnson & Johnson, Eli Lilly and Company, GlaxoSmithKline plc, and Teva Pharmaceutical Industries Ltd.
These industry leaders are focusing on developing non-opioid therapies and personalized medicine approaches to address the unmet needs in neuropathic pain management. For instance, in March, Confo Therapeutics announced a worldwide licensing agreement with Eli Lilly and Company for CFTX-1554, a novel non-opioid treatment for neuropathic pain.
✿ Neuropathic Pain Market Higher Demand in Asia-Pacific Region
The Asia-Pacific region is witnessing the fastest growth in the neuropathic pain market, attributed to the rising prevalence of chronic diseases, improving healthcare infrastructure, and increasing investments in research and development. Countries like China, India, and Japan are at the forefront, with significant advancements in clinical trials and innovative product launches.
Secure your sample copy of this report immediately!https://www.maximizemarketresearch.com/request-sample/34992/
✿ Country-Specific Insights
Consolidation Trends in Vietnam
While specific data on Vietnam's neuropathic pain market is limited, the country is part of the broader Asia-Pacific region, which is experiencing significant growth. The increasing prevalence of chronic diseases and improvements in healthcare infrastructure are expected to drive demand for neuropathic pain treatments in Vietnam.
Growth Opportunities in Thailand
Thailand is witnessing a rise in chronic diseases such as diabetes and cancer, leading to an increased incidence of neuropathic pain. The government's focus on enhancing healthcare services and the growing awareness about pain management are creating opportunities for market players to expand their presence in the country.
Innovation Trends in Japan
Japan is focusing on research and development in pain management, with a strong emphasis on non-opioid therapies. The country's aging population and the high prevalence of chronic diseases are driving the demand for effective neuropathic pain treatments. In March 2022, Daiichi Sankyo Company, Limited received approval to change the indication of the analgesic "Tarlige Tablets" from "peripheral neuropathic pain" to "neuropathic pain," reflecting the country's commitment to addressing this condition.
Market Growth in South Korea
South Korea is experiencing growth in the neuropathic pain market due to the increasing prevalence of chronic diseases and advancements in healthcare infrastructure. The country's focus on research and development, along with government initiatives to improve pain management services, is expected to drive market expansion.
Emerging Opportunities in Singapore
Singapore's well-developed healthcare system and emphasis on medical research make it a promising market for neuropathic pain treatments. The country's strategic location and supportive regulatory environment attract global pharmaceutical companies to invest in research and development activities related to pain management.
Market Expansion in the United States
The United States remains the dominant region in the neuropathic pain market, with a significant burden of chronic diseases and a strong presence of key market players. The country's focus on developing non-opioid therapies and personalized medicine approaches is driving market growth. In October 2020, Eli Lilly finalized the deal to purchase Disarm Therapeutics, enhancing its neuropathic pain portfolio.
Advancements in China
China is emerging as a significant player in the neuropathic pain market, with increasing investments in research and development and a large patient population. In July 2022, Novaremed AG and Therapeutics (Hong Kong) Limited entered into an exclusive collaboration and commercialization agreement for Novaremed's investigational drug, NRD.E1, a non-opioid therapy for diabetes-related neuropathic pain.
Opportunities in Europe
Europe is witnessing substantial growth in the neuropathic pain market due to the rising prevalence of chronic diseases and increasing investments in healthcare. Germany, in particular, is leading the market with the rapid adoption of pain management guidelines and protocols. The presence of a well-developed healthcare system and an aging population further contribute to market expansion.
To learn more about the findings of this research, please check:https://www.maximizemarketresearch.com/market-report/global-neuropathic-pain-market/34992/
✿ Neuropathic Pain Market Segment Analysis
by Drug Class
Antidepressants
Anticonvulsant
Opioids
Capsaicin
Others
by Indication
Diabetic Neuropathy
Spinal Stenosis
Chemotherapy-Induced Peripheral Neuropathy
Others
by Distribution Channel
Hospital Pharmacies
Drugs Stores and Retail Pharmacies
Online Pharmacies
✿ Get Market Research Latest Trends
Global Steam Autoclaves Market https://www.maximizemarketresearch.com/market-report/global-steam-autoclaves-market/11323/
Global Metastatic Cancer Treatment Market https://www.maximizemarketresearch.com/market-report/global-metastatic-cancer-treatment-market/22159/
Physiotherapy Services Market https://www.maximizemarketresearch.com/market-report/global-physiotherapy-services-market/87625/
global Palliative Care Market https://www.maximizemarketresearch.com/market-report/global-palliative-care-market/65300/
Traumatic Brain Injuries Treatment Market https://www.maximizemarketresearch.com/market-report/traumatic-brain-injuries-treatment-market/14716/
Microneedle Drug Delivery Systems Market https://www.maximizemarketresearch.com/market-report/microneedle-drug-delivery-systems-market/215694/
Clinical Trials Market https://www.maximizemarketresearch.com/market-report/clinical-trials-market/189646/
Complementary and Alternative Medicine Market https://www.maximizemarketresearch.com/market-report/global-complementary-and-alternative-medicine-market/74005/
Pharmaceutical Excipients Market https://www.maximizemarketresearch.com/market-report/global-pharmaceutical-excipients-market/6681/
Enteral Feeding Devices Market https://www.maximizemarketresearch.com/market-report/global-enteral-feeding-devices-market/1396/
Global Syringe and Needle Market https://www.maximizemarketresearch.com/market-report/global-syringe-and-needle-market/54138/
Blood Glucose Monitoring System Market https://www.maximizemarketresearch.com/market-report/blood-glucose-monitoring-system-market/1433/
Oxytocin Market https://www.maximizemarketresearch.com/market-report/oxytocin-market/122886/
global Medical Coding Market https://www.maximizemarketresearch.com/market-report/global-medical-coding-market/91813/
Surgical Microscopes Market https://www.maximizemarketresearch.com/market-report/surgical-microscopes-market/124768/
✿Contact Maximize Market Research:
3rd Floor, Navale IT Park, Phase 2
Pune Banglore Highway, Narhe,
Pune, Maharashtra 411041, India
sales@maximizemarketresearch.com
+91 96071 95908, +91 9607365656
✿About Maximize Market Research:
Maximize Market Research is a multifaceted market research and consulting company with professionals from several industries. Some of the industries we cover include medical devices, pharmaceutical manufacturers, science and engineering, electronic components, industrial equipment, technology and communication, cars and automobiles, chemical products and substances, general merchandise, beverages, personal care, and automated systems. To mention a few, we provide market-verified industry estimations, technical trend analysis, crucial market research, strategic advice, competition analysis, production and demand analysis, and client impact studies.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Neuropathic Pain Market to Reach USD 13.28 Billion by 2032 here
News-ID: 3994593 • Views: …
More Releases from Maximize Market Reasearch
Dedicated Server Hosting Market - Global Industry Analysis and Forecast (2025-20 …
◉ The Dedicated Server Hosting Market was valued at USD 20.15 Bn in 2024, and the total Global Dedicated Server Hosting Market revenue is expected to grow at a CAGR of 18.9% and reach nearly USD 80.49 Bn from 2025 to 2032.
This report provides a thorough examination of the Dedicated Server Hosting Market, offering valuable insights for investors, stakeholders, and industry observers. It delves into Market size, segmentation, key drivers…
Flavor Capsule Cigarette Market: Global Industry Analysis and Forecast (2024-203 …
◉The Flavor Capsule Cigarette Market size was valued at USD 2507.08 Million in 2023 and the total Flavor Capsule Cigarette revenue is expected to grow at a CAGR of 10.36% from 2024 to 2030, reaching nearly USD 4998.62 Million.
This report provides a thorough examination of the Global Flavor Capsule Cigarette Market, offering valuable insights for investors, stakeholders, and industry observers. It delves into Market size, segmentation, key drivers and restraints,…
Preclinical Imaging Market to Surge to USD 7.03 Billion by 2032: Growth at 3.98% …
◉ Revolutionizing Drug Discovery: Preclinical Imaging Market Soars to USD 4.76 Billion in 2024, Set to Reach USD 7.03 Billion by 2032
The global Preclinical Imaging market is surging, valued at USD 4.76 billion in 2024 and projected to expand at a CAGR of 3.98% from 2024 to 2032, reaching approximately USD 7.03 billion by 2032 . This growth is driven by expanding drug discovery initiatives, rising biomedical research, and…
Saffron Market to Reach USD 1.83 Billion by 2030
Global Saffron Market to Reach USD 1.83 Billion by 2030, Growing at a CAGR of 7.3%
The global saffron market is poised for significant growth, projected to expand from USD 1.12 billion in 2023 to USD 1.83 billion by 2030, registering a Compound Annual Growth Rate (CAGR) of 7.3% during the forecast period. This surge is driven by increasing demand across culinary, medicinal, and cosmetic applications, coupled with rising consumer preference…
More Releases for Neuropathic
Neuropathic Pain Management Market Size Analysis by Application, Type, and Regio …
USA, New Jersey- According to Market Research Intellect, the global Neuropathic Pain Management market in the Internet, Communication and Technology category is projected to witness significant growth from 2025 to 2032. Market dynamics, technological advancements, and evolving consumer demand are expected to drive expansion during this period.
The neuropathic pain management market is experiencing consistent growth due to rising incidences of chronic conditions such as diabetes, cancer, and neurological disorders, which…
Neuropathic Pain Market New Therapeutic Developments and Treatments
On April 08, 2025, Exactitude Consultancy., Ltd. announces the release of the report "Global Neuropathic Pain Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2034". The report is a detailed and comprehensive analysis presented by region and country, type and application. As the market is constantly changing, the report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across…
Neuropathic Pain Market: Innovative Therapies Reshaping Chronic Pain Management
In recent years, the global Neuropathic Pain Market has witnessed a dynamic shift, influenced by changing consumer preferences, technological advancements, and a growing emphasis on sustainability. The Research report on Neuropathic Pain Market presents a complete judgment of the market through strategic insights on future trends, growth factors, supplier landscape, demand landscape, Y-o-Y growth rate, CAGR, pricing analysis. It also provides and a lot of business matrices including…
The increase in Neuropathic Ocular Pain Market Size is a direct consequence of i …
As per DelveInsight, the Neuropathic Ocular Pain Market is anticipated to grow in the coming years owing to the rise in the number of prevalent cases in the 7MM, the improvement in the research and development activities, and the launch of novel therapies in the Neuropathic Ocular Pain market. There are several key players involved in developing therapies for Neuropathic Ocular Pain, like Novartis, and others.
The Neuropathic Ocular Pain market…
Neuropathic Pain Market Growth Factors and Manufacturers
Neuropathic Pain Market 2022
Global Neuropathic Pain Market to Reach US$ 8.3 Bn by 2024 End.
Machine learning and artificial intelligence have been transforming the healthcare vertical since the last few years. AI-powered healthcare solutions are there to help the patients with automation of routine tasks and data analysis. Wearable technologies are a part of exclusive physiotherapy devices that are capable of tracking and analyzing specific movements of the patients. This would…
Global Neuropathic Pain Market Research Report Forecast to 2023
Neuropathic Pain Market 2020 comprises a detailed survey of the Neuropathic Pain Market size, share, trends, extension, consumption, and share, segments, application and Forecast 2025.
Global "Neuropathic Pain" Market 2020-2025 Report contains all demographic as well as analytical data regarding market review, growth, demand, and budget analysis. The report mainly highlights the significant trends of the Neuropathic Pain market in terms of thriving companies, business methods, product values and pricing, revenue,…
